Catherine Elizabeth Harnden Keegan, MD, PhD
Charles E Lytle, Jr Research Professor of Pediatrics
Professor of Pediatrics
Section Head of Pediatric Genetics Metabolism, and Genomic Medicine
Professor of Human Genetics
Fellowship Director, Pediatric Medical Biochemical Genetics
Residency Director, Pediatric Medical Genetics and Genomics
Pediatric Genetics
1150 West Medical Center Dr.
Ann Arbor, Michigan 48109
[email protected]

Available to mentor

Catherine Elizabeth Harnden Keegan, MD, PhD
Professor
  • About
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
  • About

    Dr. Keegan is a physician-scientist boarded in Medical Genetics. She currently serves as Director of the Division of Genetics, Metabolism, and Genomic Medicine in the Department of Pediatrics. She has served as the Program Director for the Medical Genetics and Genomics Residency Program since 2017. She is Co-Director of the Michigan Medicine NORD Center of Excellence and Medical Director of the Michigan Medical Genetics Laboratory. As a practicing Pediatric Medical Geneticist, she cares for patients with a wide variety of known or suspected genetic disorders as part of her clinical responsibilities. She has significant clinical expertise in genetic evaluation of patients with Differences of Sex Development (DSDs). She also participates in a multidisciplinary clinic for patients with Turner syndrome.

    Qualifications
    • Research Fellowship
      University of Michigan Medical School, Ann Arbor, 2002
    • Medical Genetics Residency
      University of Michigan Medical School, Ann Arbor, 2001
    • Pediatrics Residency
      Boston Children's Hospital, Boston, 1999
    Center Memberships
    • Center Member
      Rogel Cancer Center
    • Center Member
      Center for Cell Plasticity and Organ Design
    Research Overview

    Dr. Keegan's current research interests include diagnosis and characterization of rare human genetic diseases. Disorders of particular interest include KDM5C-related X-linked intellectual disability, differences of sex development (DSD), and structural birth defects affecting the lower part of the body. She is also interested in models for implementation of novel therapeutics for rare diseases in the clinical setting, including gene therapy.

    Recent Publications See All Publications
    • Journal Article
      Refining the phenotype of SINO syndrome: A comprehensive cohort report of 14 novel cases.
      Alstrup M, Cesca F, Krawczun-Rygmaczewska A, López-Menéndez C, Pose-Utrilla J, Castberg FC, Bjerager MO, Finnila C, Kruer MC, Bakhtiari S, Padilla-Lopez S, Manwaring L, Keren B, Afenjar A, Galatolo D, Scalise R, Santorelli FM, Shillington A, Vezain M, Martinovic J, Stevens C, Gowda VK, Srinivasan VM, Thiffault I, Pastinen T, Baranano K, Lee A, Granadillo J, Glassford MR, Keegan CE, Matthews N, Saugier-Veber P, Iglesias T, Østergaard E. Genet Med, 2024 Nov; 26 (11): 101219 DOI:10.1016/j.gim.2024.101219
      PMID: 39033379
    • Journal Article
      Biallelic variants in CSMD1 are implicated in a neurodevelopmental disorder with intellectual disability and variable cortical malformations.
      Werren EA, Peirent ER, Jantti H, Guxholli A, Srivastava KR, Orenstein N, Narayanan V, Wiszniewski W, Dawidziuk M, Gawlinski P, Umair M, Khan A, Khan SN, Geneviève D, Lehalle D, van Gassen KLI, Giltay JC, Oegema R, van Jaarsveld RH, Rafiullah R, Rappold GA, Rabin R, Pappas JG, Wheeler MM, Bamshad MJ, Tsan Y-C, Johnson MB, Keegan CE, Srivastava A, Bielas SL. Cell Death Dis, 2024 May 30; 15 (5): 379 DOI:10.1038/s41419-024-06768-6
      PMID: 38816421
    • Journal Article
      Intellectual disability syndrome associated with a homozygous founder variant in SGSM3 in Ashkenazi Jews.
      Birnbaum R, Ezer S, Lotan NS, Eilat A, Sternlicht K, Benyamini L, Reish O, Falik-Zaccai T, Ben-Gad G, Rod R, Segel R, Kim K, Burton B, Keegan CE, Wagner M, Henderson LB, Mor N, Barel O, Hirsch Y, Meiner V, Elpeleg O, Harel T, Mor-Shakad H. J Med Genet, 2024 Feb 21; 61 (3): 289 - 293. DOI:10.1136/jmg-2023-109504
      PMID: 37833060
    • Proceeding / Abstract / Poster
      OR18-3 Case Series of 16 Patients With 17β-Hydroxysteroid Dehydrogenase Type 3 Deficiency at Five Children's Hospitals in the United States
      Groups D-TEGW, Finlayson C, Keegan C, Mohnach L, Speiser P, Mathew D, Rutter M, Schafer-Kalkhoff T, Diaz-Thomas A, Whitehead J. Journal of the Endocrine Society, 2022 Nov 1; 6 (Supplement_1): a617 - a618. DOI:10.1210/jendso/bvac150.1280
    • Book
      Nonsyndromic Disorders of Testicular Development Overview
      Keegan C, Mohnach L, Fechner PY. 2022 Aug 18;
    • Journal Article
      An Interdisciplinary Approach to Müllerian Outflow Tract Obstruction Associated with Cloacal Malformation and Cloacal Exstrophy.
      Sack BS, Speck KE, Hryhorczuk AL, Sandberg DE, Kraft KH, Ralls MW, Keegan CE, Quint EH, Dendrinos ML. J Clin Med, 2022 Jul 28; 11 (15): DOI:10.3390/jcm11154408
      PMID: 35956025
    • Journal Article
      Aberrant extracellular matrix and cardiac development in models lacking the PR-DUB component ASXL3
      McGrath BT, Tsan YC, Salvi S, Ghali N, Martin DM, Hannibal M, Keegan CE, Helms A, Srivastava A, Bielas SL. BioRxiv, 2022 Jul 16; DOI:10.1101/2022.07.14.500124
    • Journal Article
      Aberrant extracellular matrix and cardiac development in models lacking the PR-DUB component ASXL3
      McGrath BT, Tsan YC, Salvi S, Ghali N, Martin DM, Hannibal M, Keegan CE, Helms A, Srivastava A, Bielas S. 2022 Jul 16; DOI:10.1101/2022.07.14.500124
    Featured News & Stories
    Department News
    Highlighted Publications - May 2024
    Department of Human Genetics faculty are involved in widely diverse areas of research, from Genome Structure and Function research to Evolutionary and Population Genetics.